BMRA Stock Catalyst: Biomerica, Inc. Granted Approval for Fortel® PSA Screening Test by UAE Ministry of Health and Prevention

Jan 15, 2025 · 7:46pm ET

The approval was announced on January 16, 2025.

Max move

+257.6%

High of day $10.16

Sparker timei

7:46pm ET

BMRA · Jan 15, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Biomerica, Inc. (XNAS: BMRA) received approval for its Fortel® PSA Screening Test from the United Arab Emirates Ministry of Health and Prevention. The announcement was made on January 16, 2025.

The approval allows Biomerica to market and distribute the Fortel® PSA Screening Test within the UAE. This test is designed to aid in the early detection of prostate cancer.

As of the latest available data, Biomerica has a free float of 2,582,400 shares and 2,948,000 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time BMRA sparks.

Download Sniper App →

Catch the next BMRA-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →